Natera Inc (NTRA)

Apr 18, 2025

Long Term Trading Analysis for (NTRA) - news.stocktradersdaily.com

Apr 18, 2025

Apr 17, 2025

Here's How Much $100 Invested In Natera 5 Years Ago Would Be Worth Today - Benzinga

Apr 17, 2025

Apr 17, 2025

The Blood Test Revolution Driving These Three Stocks - Investor's Business Daily

Apr 17, 2025

Apr 16, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 16, 2025

Apr 15, 2025

Lobbying Update: $140,000 of NATERA INC lobbying was just disclosed - Nasdaq

Apr 15, 2025

Apr 15, 2025

When will cancer return? Personalized Signatera blood test can find early signs of disease - Austin American-Statesman

Apr 15, 2025

Apr 12, 2025

Natera (NasdaqGS:NTRA) Climbs 11% in One Week - simplywall.st

Apr 12, 2025

Apr 10, 2025

Barclays Adjusts Natera (NTRA) Price Target Amid Industry Challe - GuruFocus

Apr 10, 2025

Apr 10, 2025

Assessing Natera: Insights From 10 Financial Analysts - Benzinga

Apr 10, 2025

Apr 10, 2025

When Will Natera, Inc. (NASDAQ:NTRA) Turn A Profit? - Yahoo Finance

Apr 10, 2025

Apr 10, 2025

Natera price target lowered to $160 from $200 at Barclays - TipRanks

Apr 10, 2025

Apr 08, 2025

Natera, Inc. (NTRA): Among Stocks with Buy Ratings that Hedge Funds Love - Insider Monkey

Apr 08, 2025

Apr 08, 2025

3 Reasons NTRA Has Explosive Upside Potential - Yahoo Finance

Apr 08, 2025

Apr 08, 2025

Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.

Apr 08, 2025

Apr 07, 2025

15 Stocks with Buy Ratings that Hedge Funds Love - Insider Monkey

Apr 07, 2025

Apr 07, 2025

27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks - Yahoo Finance

Apr 07, 2025

Apr 07, 2025

Immuno-Oncology Stocks Weather Market Volatility Despite Strong Q4News and Statistics - IndexBox

Apr 07, 2025

Apr 07, 2025

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY) - Yahoo Finance

Apr 07, 2025

Apr 06, 2025

Multi-Cancer Early Detection Market Critical Analysis with Expert Opinion| GRAIL, Natera, Elypta - openPR.com

Apr 06, 2025

Apr 06, 2025

Insider Selling: Natera, Inc. (NASDAQ:NTRA) CFO Sells 2,562 Shares of Stock - MarketBeat

Apr 06, 2025

Apr 04, 2025

Natera co-founder Sheena Jonathan sells $826,326 in stock By Investing.com - Investing.com Australia

Apr 04, 2025

Apr 04, 2025

Natera co-founder Sheena Jonathan sells $826,326 in stock - Investing.com India

Apr 04, 2025

Apr 04, 2025

Is the Market Bullish or Bearish on Natera? - Benzinga

Apr 04, 2025

Apr 04, 2025

Natera’s president of clinical diagnostics sells $421,428 in stock By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 04, 2025

Natera director Marcus Gail boxer sells $563,100 in stock By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 03, 2025

Natera director Marcus Gail boxer sells $563,100 in stock - Investing.com India

Apr 03, 2025

Apr 03, 2025

Natera’s president of clinical diagnostics sells $421,428 in stock - Investing.com

Apr 03, 2025

Apr 02, 2025

Natera Inc (NTRA) Shares Up 3.33% on Apr 2 - GuruFocus

Apr 02, 2025

Apr 01, 2025

Natera CFO Michael Burkes sells $354,603 in stock By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Natera CEO Steven Leonard sells $3.56 million in stock By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Natera’s chief legal officer Daniel Rabinowitz sells $194,326 in stock By Investing.com - Investing.com Australia

Apr 01, 2025

Apr 01, 2025

Natera CEO Steven Leonard sells $3.56 million in stock - Investing.com Australia

Apr 01, 2025

Apr 01, 2025

Natera CFO Michael Burkes sells $354,603 in stock - Investing.com

Apr 01, 2025

Apr 01, 2025

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 27, 2022 in Natera LawsuitNTRA - Newsfile

Apr 01, 2025

Apr 01, 2025

Is Natera, Inc. (NASDAQ:NTRA) Trading At A 23% Discount? - simplywall.st

Apr 01, 2025

Apr 01, 2025

Transforming Colorectal Cancer Management with Tumor-Informed ctDNA Testing - Inside Precision Medicine

Apr 01, 2025

Apr 01, 2025

Natera’s chief legal officer Daniel Rabinowitz sells $194,326 in stock - Investing.com

Apr 01, 2025

Mar 30, 2025

Quantbot Technologies LP Makes New $878,000 Investment in Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Mar 30, 2025

Mar 29, 2025

EFG Asset Management North America Corp. Sells 9,323 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat

Mar 29, 2025

Mar 25, 2025

Game-Changing Heart Transplant Monitoring Trial Results: 1,100+ Patient Study Could Transform Post-Surgery Care - Stock Titan

Mar 25, 2025

Mar 25, 2025

Natera’s Busy 2025 Continues - The Healthcare Technology Report.

Mar 25, 2025

Mar 25, 2025

(PDF) Understanding the clinical genetics of kidney stone disease using the Natera Renasight panel - ResearchGate

Mar 25, 2025

Mar 24, 2025

Is Natera, Inc. (NTRA) the Best Diagnostics Stock to Invest in Right Now? - Insider Monkey

Mar 24, 2025

Mar 24, 2025

Natera Investors Get Class Status in Prenatal Screening Lawsuit - Bloomberg Law News

Mar 24, 2025

Mar 23, 2025

12 Best Diagnostics Stocks to Invest In Right Now - Insider Monkey

Mar 23, 2025

Mar 21, 2025

Guardant Health gains amid $292.5M verdict against Natera over false advertising claims (update) - MSN

Mar 21, 2025

Mar 20, 2025

Natera CFO Michael Burkes sells $115,661 in company stock By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

Here’s What Lifted Natera (NTRA) in Q4 and 2024 - MSN

Mar 20, 2025

Mar 20, 2025

Natera’s president John Fesko sells $116,099 in stock By Investing.com - Investing.com Canada

Mar 20, 2025

Mar 20, 2025

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack - Yahoo Finance

Mar 20, 2025